# Cholangiocarcinoma trials, no drug phase: 38 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 38 trials with no drug phase for cholangiocarcinoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting cholangiocarcinoma trials with no drug phase: 38 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/cholangiocarcinoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 38
- Recruiting or not yet: 38
- Read on: November 19, 2026

## Trials

The 25 newest of 38, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916870 | Photodynamic Therapy Combined With a Self-expandable Radioactive Particle-loaded Biliary Stent for Unresectable Extrahepatic... | Sponsor not shown (see the record) | Not applicable | Recruiting | Extrahepatic Cholangiocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916870) |
| August 17, 2026 | NCT07768085 | Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT | Shengjing Hospital | Not applicable | Not yet recruiting | Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Hepatic Metastasis, Hepatic Hemangioma, Cyst... | 40,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768085) |
| August 12, 2026 | NCT07760038 | Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Intrahepatic Cholangiocarcinoma (Icc), Liver Injury | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760038) |
| August 12, 2026 | NCT07760012 | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors | Peking University Third Hospital | Not applicable | Recruiting | Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760012) |
| June 12, 2026 | NCT07645742 | Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors | West Virginia University | Not applicable | Not yet recruiting | Cancer (Advanced Stage) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645742) |
| June 2, 2026 | NCT07620080 | EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Cholangiocarcinoma, Biliary Stricture | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620080) |
| April 30, 2026 | NCT07558304 | Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial) | Hospital de Clinicas de Porto Alegre | Not applicable | Recruiting | Cholangiocarcinoma, Bile Duct Neoplasms, Malignant Biliary Obstruction | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558304) |
| April 29, 2026 | NCT07557225 | 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors | Peking University First Hospital | Not applicable | Recruiting | Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer, Ovarian Cancer... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07557225) |
| March 17, 2026 | NCT07476651 | Scout Dose of Resin Microspheres | Seoul National University Hospital | Not applicable | Recruiting | Radioembolization, Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (ICC), Liver Metastasis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476651) |
| December 4, 2025 | NCT07263217 | Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Cholangiocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263217) |
| November 19, 2025 | NCT07235007 | Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma | Aichi Medical University | Not applicable | Recruiting | Extrahepatic Cholangiocarcinoma | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235007) |
| November 4, 2025 | NCT07224464 | The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. | New Phase Ltd. | Not applicable | Recruiting | Metastatic Solid Tumors, Stage 4 Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224464) |
| October 6, 2025 | NCT07208526 | A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST | Shanghai Zhongshan Hospital | Not applicable | Not yet recruiting | Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy, TDTP-RECIST, GOLP Regimen | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208526) |
| September 4, 2025 | NCT07155525 | Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas | Minia University | Not applicable | Recruiting | Pancreatic Cancer, Periampullary Cancer, Duodenal Cancer, Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma... | 194 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07155525) |
| August 11, 2025 | NCT07115420 | Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically... | Waikato Hospital | Not applicable | Not yet recruiting | Malignant Biliary Obstruction, Advanced Pancreatic Cancer and Cholangiocarcinoma, Inoperable Malignant Biliary... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07115420) |
| May 25, 2025 | NCT06990659 | Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC) | University Hospital, Angers | Not applicable | Recruiting | Hepato Cellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06990659) |
| May 14, 2025 | NCT06971848 | Evaluation of Skin Tests in Biotherapy Allergies | University Hospital, Angers | Not applicable | Recruiting | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Melanoma Neoplasms, Small Cell Bronchial... | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06971848) |
| May 9, 2025 | NCT06964425 | Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study | University Hospital Olomouc | Not applicable | Recruiting | Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma, Perihilar... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06964425) |
| April 6, 2025 | NCT06914648 | The Dragon PLC Trial (DRAGON-PLC) | Maastricht University | Not applicable | Recruiting | Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma | 358 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06914648) |
| April 4, 2025 | NCT06910722 | Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy | Assistance Publique - Hôpitaux de Paris | Not applicable | Recruiting | Intrahepatic Cholangiocarcinoma, Locally Advanced Intrahepatic Cholangiocarcinoma | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06910722) |
| March 27, 2025 | NCT06899152 | HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver... | Montefiore Medical Center | Not applicable | Recruiting | Liver Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer, Cholangiocarcinoma, Liver Metastases | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06899152) |
| December 16, 2024 | NCT06735560 | Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN | Nantes University Hospital | Not applicable | Recruiting | Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Neuroendocrine Tumors | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06735560) |
| August 6, 2024 | NCT06539377 | Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma | Jena University Hospital | Not applicable | Not yet recruiting | Living Donor Liver Transplantation, Liver Transplantation, Neoadjuvant Therapy | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06539377) |
| May 30, 2024 | NCT06434493 | Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma | The Christie NHS Foundation Trust | Not applicable | Recruiting | Cholangiocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06434493) |
| April 1, 2024 | NCT06340646 | Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) | Washington University School of Medicine | Not applicable | Recruiting | Cholangiocarcinoma, Multiple Myeloma, Colon Cancer, Rectal Cancer | 990 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06340646) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| University Hospital, Angers | 2 |
| The Christie NHS Foundation Trust | 1 |
| Washington University School of Medicine | 1 |
| West Virginia University | 1 |
| Nantes University Hospital | 1 |
| Waikato Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Azienda Sanitaria Ospedaliera | 1 |
| University of Miami | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Montefiore Medical Center | 1 |
| Mayo Clinic | 1 |
| Aichi Medical University | 1 |
| University of California, Davis | 1 |
| McMaster University | 1 |
| Fudan University | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Peking University Third Hospital | 1 |
| New Phase Ltd. | 1 |
| University Hospital Olomouc | 1 |
| University of California, Irvine | 1 |
| Jena University Hospital | 1 |
| Seoul National University Hospital | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 10 |
| China | 9 |
| France | 4 |
| United Kingdom | 2 |
| Italy | 2 |
| South Korea | 2 |
| Germany | 2 |
| Norway | 2 |
| New Zealand | 1 |
| Japan | 1 |
| Thailand | 1 |
| Czechia | 1 |
| Brazil | 1 |
| Egypt | 1 |
| Mexico | 1 |
| Australia | 1 |
| Austria | 1 |
| Belgium | 1 |
| Canada | 1 |
| Netherlands | 1 |
| Sweden | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Hong Kong style cafes in the United States](https://specstream.ai/data/businesses/hong-kong-style-cafes/united-states)
- [Bathtub and sink repair companies in the United States](https://specstream.ai/data/businesses/bathtub-and-sink-repair-companies/united-states)
- [Real estate investment firms in the United States](https://specstream.ai/data/businesses/real-estate-investment-firms/united-states)
- [Grout companies in the United States](https://specstream.ai/data/businesses/grout-companies/united-states)
- [B2B oil refinery companies in the United States](https://specstream.ai/data/businesses/b2b-oil-refinery-companies/united-states)
- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
